MiMedx Group, Inc (MDXG) is a publicly traded Healthcare sector company. As of September 23, 2026, MDXG trades at $4.92 with a market cap of $719.46M and a P/E ratio of 94.30. MDXG moved -3.14% today. Year to date, MDXG is -26.39%; over the trailing twelve months it is -32.91%. Its 52-week range spans $3.03 to $8.98. Analyst consensus is strong buy with an average price target of $7.67. Rallies surfaces MDXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MDXG news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.92 |
| Market Cap | $719.46M |
| P/E Ratio | 94.30 |
| EPS | $0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.98 |
| 52-Week Low | $3.03 |
| Volume | 841.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $355.17M |
| Net Income | $6.24M |
| Gross Margin | 78.85% |
3 analysts cover MDXG: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.67.